FORTE BIOSCIENCES, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- FORTE BIOSCIENCES, INC. stock issued during period, value, new issues for the quarter ending 2026-06-30 was $140.25M.
- FORTE BIOSCIENCES, INC. stock issued during period, value, new issues for the quarter ending 2022-09-30 was $7.12M.
- FORTE BIOSCIENCES, INC. stock issued during period, value, new issues for the quarter ending 2020-06-30 was $24.02M, a 296.17% increase year-over-year.
- FORTE BIOSCIENCES, INC. stock issued during period, value, new issues for the quarter ending 2019-12-31 was $0.00.
- FORTE BIOSCIENCES, INC. stock issued during period, value, new issues for fiscal 2022 was $7.12M.
- FORTE BIOSCIENCES, INC. stock issued during period, value, new issues for fiscal 2020 was $66.70M, a 780.51% increase from fiscal 2019.
- FORTE BIOSCIENCES, INC. stock issued during period, value, new issues for fiscal 2019 was $7.58M, a 72.94% decline from fiscal 2018.
- FORTE BIOSCIENCES, INC. stock issued during period, value, new issues for fiscal 2018 was $28.00M, a 67.80% decline from fiscal 2017.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-06-30 | $140.25M 10-Q · filed 2026-08-12 | |
| 2022-12-31 | $7.12M 10-K · filed 2024-03-18 | |
| 2022-09-30 | $7.12M 10-Q · filed 2023-11-13 | |
| 2020-12-31 | $66.70M 10-K · filed 2022-03-31 | |
| 2020-06-30 | $24.02M 10-Q · filed 2021-11-08 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $7.58M 10-K · filed 2020-02-27 |
| 2019-09-30 | $9.00K 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $6.06M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $1.50M 10-Q · filed 2020-04-23 | |
| 2018-12-31 | $28.00M 10-K · filed 2020-02-27 | |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $86.95M 10-K · filed 2020-02-27 |
| 2017-09-30 | $6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 |